Interventions for Cardiovascular Patients with Type D Personality: A Systematic Review

Xi Cao1, Eliza M L Wong2, Kai Chow Choi2

  • 1Doctoral candidate, the Nethersole School of Nursing, the Chinese University of Hong Kong, Hong Kong.

Insights

Cardiac rehabilitation effectively improves psychological health, physical functioning, and quality of life in patients with cardiovascular disease and Type D personality. Further research is needed to determine optimal intervention delivery formats.

Area of Science:

  • Cardiology
  • Psychology
  • Rehabilitation Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Type D personality is an emerging risk factor associated with poorer cardiac outcomes.
  • Interventions for CVD patients with Type D personality warrant investigation.

Purpose of the Study:

  • To synthesize evidence on interventions for cardiac patients with Type D personality.
  • To evaluate the effects of these interventions on patient health outcomes.

Main Methods:

  • Systematic review of experimental studies published in English and Chinese databases up to December 2014.
  • Inclusion criteria focused on interventions for cardiac patients with Type D personality.
  • Outcomes assessed included psychological health, physical functioning, and quality of life.

Main Results:

  • Four studies (1 RCT, 3 pre-post) involving 967 patients were included.
  • Interventions consisted of cardiac rehabilitation programs with exercise, education, and psychological support.
  • Cardiac rehabilitation significantly improved anxiety, depression, physical functioning, and quality of life.

Conclusions:

  • Cardiac rehabilitation shows promise as an effective intervention for improving health in cardiac patients with Type D personality.
  • Preliminary evidence supports its use, but optimal delivery requires further exploration.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
740
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
520
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
837
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398